(Q45300658)

11 December 2017

title

Functional increase of brain histaminergic signaling in Huntington's disease (English)

1 reference

11 December 2017

0 references

2

1 reference

11 December 2017

Dick F Swaab

7

0 references

Raymund A. C. Roos

6

object named as

Raymund A C Roos

1 reference

11 December 2017

Daniel J van Wamelen

1

1 reference

11 December 2017

N Ahmad Aziz

3

1 reference

11 December 2017

Jasper J Anink

4

1 reference

11 December 2017

Ai-Min Bao

5

1 reference

11 December 2017

publication date

27 December 2010

1 reference

11 December 2017

1 reference

11 December 2017

volume

21

1 reference

11 December 2017

issue

4

1 reference

11 December 2017

page(s)

419-427

1 reference

Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Basic local alignment search tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Dopamine and glutamate in Huntington's disease: A balancing act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

The physiology of brain histamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Neuronal histamine and the interplay of memory, reinforcement and emotions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

RNA integrity and the effect on the real-time qRT-PCR performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Histamine in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Cortical and striatal neurone number in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Regional and cellular gene expression changes in human Huntington's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

A quantitative in situ hybridization protocol for formalin-fixed paraffin-embedded archival post-mortem human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Orexin loss in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

The current clinical management of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Hypothalamic involvement in Huntington's disease: an in vivo PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Morphometric analysis of the prefrontal cortex in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Efficient and unbiased estimation of volume and area of tissue components and cell number in gingival biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2010.00465.X

10.1111/J.1750-3639.2010.00465.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference